23andMe

A European fertility group advocates for international limits on sperm donors due to concerns over donor-conceived individuals discovering large numbers of siblings and genetic risks. Cases like a Dutch donor who fathered 550-600 children and a Danish donor whose genetic mutation caused cancer in offspring highlight these issues.

A United States bankruptcy judge ordered genetic testing company 23andMe to pay a nearly $50 million settlement for a 2023 hack that led to the data leak of millions of their customers.

A bankruptcy judge in St. Louis approved a $46.75 million settlement for victims of the 2023 23andMe data breach, with $32.46 million still owed to affected individuals.

The bankruptcy admin approved a $47 million settlement for victims of a data breach at 23andMe, where approximately 7 million customers had their data stolen starting in April 2023. Much of the stolen information was later posted on the dark web.

23andMe experienced a rise, faced bankruptcy, and underwent a rebirth.

California Atty. Gen. Rob Bonta filed a lawsuit against the genetic testing company formerly known as 23andMe for failing to protect its customers' data. The suit alleges a data breach due to inadequate security measures.

California Attorney General Rob Bonta filed a lawsuit against the genetic testing company formerly known as 23andMe for failing to protect customer data. The suit alleges a data breach that compromised user information.

California Atty. Gen. Rob Bonta filed a lawsuit against the genetic testing company formerly known as 23andMe for failing to protect its customers' data. The suit alleges the company failed to safeguard sensitive genetic information.

California's attorney general Rob Bonta sued the genetic testing company formerly known as 23andMe, alleging it failed to protect sensitive user data in a 2023 breach affecting nearly 7 million people nationwide.

California's attorney general Rob Bonta sued 23andMe, alleging the company failed to protect sensitive user data in a 2023 breach affecting nearly 7 million people. The lawsuit claims the breach compromised user privacy.

California Attorney General Rob Bonta filed a lawsuit against 23andMe, now Chrome Holding Co., over the company's failure to protect sensitive customer genetic and personal information. The case involves a 2023 breach that exposed health data.

A lawsuit alleges that 23andMe failed to protect user data during a 2023 breach, accusing the genetic testing company of not safeguarding user information.

California's attorney general's office sued 23andMe for data protection failures leading to a 2023 breach that exposed sensitive genetic data. The lawsuit alleges the company failed to secure customer data and misled consumers about the breach's severity, with compromised information sold on the dark web during a period of rising hate crimes.

California AG Rob Bonta has sued 23andMe over a 2023 data breach that led to the sale of 7 million users' data on the dark web.

California’s attorney general sued Chrome Holding Co. (formerly 23andMe) for failing to protect user data in a 2023 breach affecting 7 million people. The breach, using credential stuffing from a 2017 MyHeritage data leak, allowed attackers to access 14,000 accounts and steal genetic data, health reports, and relative information, which was later sold on the dark web. The lawsuit seeks penalties and injunctions against the company for violating privacy laws.

The article accuses the CIA of using DNA testing companies Ancestry and 23andMe to track alien bloodlines through millions of DNA tests. The claim suggests a conspiracy involving government surveillance of genetic data for undisclosed purposes.

The CIA has been accused of utilizing genetic data from Ancestry and 23andMe to identify alien bloodlines within millions of DNA tests, raising privacy and ethical concerns.

23andMe plans to connect users' DNA data with medical records, offering a 360-degree view of personal health. The company will provide an AI-written Health Summary and utilize HealthEx technology to make medical records more portable. This development aims to improve personalized disease risk predictions.

23andMe is potentially selling data beyond genetic information, including personal health details, drinking habits, and risk tolerance collected through survey questions.